Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

15.360
-0.140-0.90%
Volume:3.14M
Turnover:48.24M
Market Cap:47.94B
PE:5.74
High:15.500
Open:15.470
Low:15.260
Close:15.500
52wk High:21.258
52wk Low:15.187
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:0.54
T/O Rate:0.23%
Dividend:0.79
Dividend Rate:5.14%
EPS(LYR):2.677
ROE:8.04%
ROA:2.56%
PB:0.48
PE(LYR):5.74
PS:0.07

Loading ...

Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors

Reuters
·
Aug 24

Sinopharm Group H1 Revenue RMB 282,799.6 Million

THOMSON REUTERS
·
Aug 24

Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion

Reuters
·
Aug 24

Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan

MT Newswires Live
·
Aug 20

Sinopharm Group Sells 42.19% of Guorui Pharmaceutical; SSPC to Assume Control in RMB406.36 Million Connected Deal

Bulletin Express
·
Aug 19

Sinopharm Group and Partners to Divest 51% Stake in Guorui Pharma for RMB 406 Million

Stock News
·
Aug 19

Sinopharm Sells 30.13% Stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 Million

Reuters
·
Aug 19

Sinopharm Group - to Sell 30.13% Stake in China National Medicines Guorui Pharmaceutical for Rmb240.0731 Mln

THOMSON REUTERS
·
Aug 19

Sinopharm (CNCM LTD) H1 2026 Revenue Up 4.27% to RMB 26.73 Billion; Net Profit Falls 7.25%

Bulletin Express
·
Aug 19

SINOPHARM Reports Mid-Year Results for Its Medical Device Unit

Stock News
·
Aug 19

China National Medical Device, Sinopharm Subsidiary, Posts H1 Operating Profit Down 12.34% to RMB 599.37 Million

Reuters
·
Aug 19

Sinopharm Announces Changes to Board Committee Composition Effective 18 August 2026

Bulletin Express
·
Aug 18

Sinopharm Appoints Yang Binghua to Board Strategy and Investment Committee

Reuters
·
Aug 18

Sinopharm Group - China National Accord Medicines H1 2026 Net Profit Attributable Rmb606.2 Mln, Down 8.97% Y/Y

THOMSON REUTERS
·
Aug 17

Sinopharm Accord, Sinopharm Group Subsidiary, Posts H1 Net Profit RMB 606 Million, Down 8.97%

Reuters
·
Aug 17

Earning Preview: SINOPHARM this quarter’s revenue is expected to increase by 0%, and institutional views are cautious

Earnings Agent
·
Aug 14

Sinopharm Group Stock Slides 1.3% in Hong Kong

Dow Jones
·
Aug 11

SINOPHARM Schedules 21 August 2026 Board Meeting to Approve H1 2026 Unaudited Results

Bulletin Express
·
Aug 07

Sinopharm Group Stock Sheds 0.8% in Hong Kong

Dow Jones
·
Aug 07

FMR LLC Reduces Stake in SINOPHARM by Approximately 1.4 Million Shares at Around HKD 17.05 Each

Stock News
·
Aug 04